Researchers from the University of Texas at Arlington (UTA) have developed a rapid, accurate, and precise method to quantify water content in solid pharmaceutical drugs using headspace gas chromatography (HSGC) (1).
Photo Credit: moodboard/Getty Images
Researchers from the University of Texas at Arlington (UTA) have developed a rapid, accurate, and precise method to quantify water content in solid pharmaceutical drugs using headspace gas chromatography (HSGC) (1).
The concentrations of water within pharmaceutical compounds can affect the physiochemical properties of a finished drug (1), resulting in a wide range of variations in the solid flow properties (1) or inconsistencies in the dosage (2). An increase in water can even allow harmful microorganisms to grow within the drug formulations causing adverse effects (3).
“Every therapeutic drug has a narrow range of optimal water content, which needs to be controlled to avoid potential adverse effects on patients,” said Daniel Armstrong, UTA’s Robert A. Welch Chair in Chemistry and leader of the project.
Currently, Karl Fischer titration (KFT) is the method recognized by the US Food and Drug Administration (FDA) for water determination in therapeutic drug formulations (4). However, this technique requires rigorous sample and condition control to obtain reliable results. For example, one case study found that if air with a relative humidity of 50% is introduced to the titration vessel, the measurement of water will increase by 1 mg (5).
This new method revolves around the use of ionic liquids (ILs), which are used for GC stationary phases but are also used as solvents in HSGC. The tunable nature of ILs for desired traits such as solubilizing power, thermal stability, viscosity, and hydrophobicity allows for a unique selectivity as a GC stationary phase (6,7). The resultant columns can have a high selectivity between common residual solvents and water (8) and can change anions to allow for the use of trifluoromethanesulfonate (TFO-) for better peak shape for water. They have high thermal stability, and lack volatility and degradation products, which eliminates solvent peaks and reduces the number of contaminant peaks (6,7).
When compared to alternative methods, including a recently developed near-infrared spectroscopy (NIRS) method, the new method was found to be significantly quicker, taking an average of 10 minutes to complete a measurement but also significantly more accurate than the KFT and NIRS methods, respectively.
“This is an example of where basic research on ionic liquids led to a very practical outcome with clear business implications for the pharmaceutical industry,” said Frederick MacDonnell, chair of UTA’s Department of Chemistry and Biochemistry.
“In addition to other advantages like speed and lower costs, our new system can also be automated, reducing labour costs for manufacturers with potential economic benefits for consumers,” said Armstrong.
Further benefits of the method include the small amount of sample required - approximately 10 mg. The researchers responsible hope the method can be used to reduce the price of pharmaceuticals by reducing costs in production. - L.B.
References
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.